November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Double Down On Shorting Nvidia In 2025
Apple: Much To Prove In 2025
Apple’s AI Chips Could Shake Up The Market (Rating Upgrade)
Apple Moves Ahead In AI With New Broadcom Deal
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
November 24, 2024 Latest Finance Management Regulations in Australia
November 24, 2024 Finance Management Education Resources
November 18, 2024 Best Forex Trading Tools
November 18, 2024 Best Backtesting Software For Traders
Allarity Therapeutics (ALLR) stock forecast for 2026
Updated: December 12, 2024 (19:36)
Sector: HealthcareThe share price of Allarity Therapeutics, Inc. (ALLR) now
50/200 Day Moving Average: $2.206 / $64.88
This figure corresponds to the Average Price over the previous 50/200 days. For Allarity Therapeutics stocks, the 50-day moving average is the resistance level today.
For Allarity Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Allarity Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Allarity Therapeutics stock price in 2026. How much will one Allarity Therapeutics share be worth in 2026? Is it worth taking profit / loss on ALLR stock now or waiting? What are analysts' forecasts for Allarity Therapeutics stock?
We forecast Allarity Therapeutics stock performance using neural networks based on historical data on ALLR stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Allarity Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Allarity Therapeutics analysts is $5. Today 200 Day Moving Average is the resistance level (64.88 $). 50 Day Moving Average is the resistance level (2.206 $).
Historical and forecast chart of Allarity Therapeutics, Inc. stock
The chart below shows the historical price of Allarity Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ALLR stock price can be found in the table below.
Allarity Therapeutics is a late clinical-stage, precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers guided by its proprietary drug response predictor technology, the DRP platform.
Allarity Therapeutics (ALLR) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.03 | -0.03 | 0.07 | 144.41 % |
| Feb | 0.00 | 0.00 | 0.00 | 1,546.66 % |
| Mar | 0.00 | 0.00 | 0.00 | 1,269.56 % |
| Apr | 0.00 | -0.01 | 0.00 | 372.79 % |
| May | -0.01 | -0.02 | 0.00 | 890.32 % |
| Jun | -0.04 | -0.08 | -0.01 | 536.58 % |
| Jul | -0.06 | -0.11 | 0.01 | 2,290.92 % |
| Aug | 0.12 | 0.00 | 0.41 | 98.79 % |
| Sep | -0.01 | -0.05 | 0.02 | 364.07 % |
| Oct | 0.00 | 0.00 | 0.01 | 106.15 % |
| Nov | 0.00 | 0.00 | 0.00 | 238.99 % |
| Dec | -0.01 | -0.03 | 0.01 | 509.47 % |
Allarity Therapeutics information and performance
210 BROADWAY, SUITE 201, CAMBRIDGE, MA, US
Market capitalization of the Allarity Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALLR shares in the company outstanding by the market price of one share.
EBITDA of Allarity Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Allarity Therapeutics price target for 2026 by month
Target values for the price of one Allarity Therapeutics share for Jan 2026.
In Jan, the Positive dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 144.409% volatility is expected.
Pessimistic target level: -0.03
Optimistic target level: 0.07
Target values for the price of one Allarity Therapeutics share for Feb 2026.
In Feb, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 1,546.663% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Target values for the price of one Allarity Therapeutics share for Mar 2026.
In Mar, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 1,269.564% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Target values for the price of one Allarity Therapeutics share for Apr 2026.
In Apr, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 372.789% volatility is expected.
Pessimistic target level: -0.01
Optimistic target level: 0.00
Target values for the price of one Allarity Therapeutics share for May 2026.
In May, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 890.322% volatility is expected.
Pessimistic target level: -0.02
Optimistic target level: 0.00
Target values for the price of one Allarity Therapeutics share for Jun 2026.
In Jun, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 536.585% volatility is expected.
Pessimistic target level: -0.08
Optimistic target level: -0.01
Target values for the price of one Allarity Therapeutics share for Jul 2026.
In Jul, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 2,290.920% volatility is expected.
Pessimistic target level: -0.11
Optimistic target level: 0.01
Target values for the price of one Allarity Therapeutics share for Aug 2026.
In Aug, the Positive dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 98.789% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.41
Target values for the price of one Allarity Therapeutics share for Sep 2026.
In Sep, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 364.072% volatility is expected.
Pessimistic target level: -0.05
Optimistic target level: 0.02
Target values for the price of one Allarity Therapeutics share for Oct 2026.
In Oct, the Positive dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 106.149% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.01
Target values for the price of one Allarity Therapeutics share for Nov 2026.
In Nov, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 238.993% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Target values for the price of one Allarity Therapeutics share for Dec 2026.
In Dec, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 509.474% volatility is expected.
Pessimistic target level: -0.03
Optimistic target level: 0.01
